Tudor Investment Corp’s Lexicon Pharmaceuticals LXRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-23,531
Closed -$39.5K 1847
2024
Q2
$39.5K Buy
+23,531
New +$39.5K ﹤0.01% 1436
2024
Q1
Sell
-47,101
Closed -$72.1K 1743
2023
Q4
$72.1K Hold
47,101
﹤0.01% 1383
2023
Q3
$51.3K Sell
47,101
-1,484
-3% -$1.62K ﹤0.01% 1411
2023
Q2
$111K Buy
48,585
+37,585
+342% +$86.1K ﹤0.01% 1424
2023
Q1
$27K Buy
+11,000
New +$27K ﹤0.01% 1486
2022
Q3
Sell
-105,106
Closed -$195K 1810
2022
Q2
$195K Sell
105,106
-34,495
-25% -$64K 0.01% 1380
2022
Q1
$292K Sell
139,601
-11,347
-8% -$23.7K 0.01% 1288
2021
Q4
$595K Buy
150,948
+42,407
+39% +$167K 0.01% 1090
2021
Q3
$522K Buy
108,541
+93,480
+621% +$450K 0.01% 1115
2021
Q2
$69K Buy
+15,061
New +$69K ﹤0.01% 1441
2020
Q4
Sell
-18,034
Closed -$26K 1482
2020
Q3
$26K Sell
18,034
-17,150
-49% -$24.7K ﹤0.01% 1212
2020
Q2
$70K Sell
35,184
-89
-0.3% -$177 ﹤0.01% 1088
2020
Q1
$69K Buy
+35,273
New +$69K 0.01% 949
2017
Q4
Sell
-14,406
Closed -$177K 1176
2017
Q3
$177K Buy
+14,406
New +$177K ﹤0.01% 963
2017
Q2
Sell
-25,827
Closed -$370K 1212
2017
Q1
$370K Sell
25,827
-4,747
-16% -$68K 0.01% 859
2016
Q4
$423K Sell
30,574
-11,276
-27% -$156K 0.01% 790
2016
Q3
$756K Buy
41,850
+29,499
+239% +$533K 0.02% 512
2016
Q2
$177K Buy
+12,351
New +$177K ﹤0.01% 1264
2015
Q4
Sell
-15,299
Closed -$164K 1610
2015
Q3
$164K Buy
+15,299
New +$164K 0.01% 1310
2015
Q2
Sell
-4,175
Closed -$28K 1547
2015
Q1
$28K Sell
4,175
-3,439
-45% -$23.1K ﹤0.01% 1400
2014
Q4
$48K Buy
7,614
+3,439
+82% +$21.7K ﹤0.01% 1382
2014
Q3
$41K Buy
4,175
+655
+19% +$6.43K ﹤0.01% 1297
2014
Q2
$40K Hold
3,520
﹤0.01% 1117
2014
Q1
$43K Sell
3,520
-961
-21% -$11.7K ﹤0.01% 1139
2013
Q4
$56K Buy
+4,481
New +$56K ﹤0.01% 1217